Literature DB >> 6634558

Incomplete suppression of parathyroid hormone activity in sarcoidosis presenting with hypercalcaemia.

R R Ghose, J S Woodhead, R C Brown.   

Abstract

An adult patient presenting in summertime with sarcoidosis and demonstrating raised levels of serum calcium and 1,25-dihydroxycholecalciferol was observed to have a serum immuno-reactive parathyroid hormone concentration in the mid-normal range. Renal function was normal. Corticosteroid administration quickly depressed serum calcium and 1,25-dihydroxycholecalciferol into the normal range; serum parathyroid hormone also fell to low levels. It was concluded that corticosteroid suppression, when incorporating measurements of serum calcium and 1,25-dihydroxycholecalciferol concentrations, can distinguish between sarcoidosis-related hypercalcaemia and primary hyperparathyroidism. The significance of the changes in parathyroid hormone concentration is obscure.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6634558      PMCID: PMC2417623          DOI: 10.1136/pgmj.59.695.572

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  15 in total

1.  Seasonal influence of sunlight on the hypercalcemia of sarcoidosis.

Authors:  R L TAYLOR; H J LYNCH; W G WYSOR
Journal:  Am J Med       Date:  1963-02       Impact factor: 4.965

Review 2.  Metabolism and mechanism of action of vitamin D.

Authors:  H F DeLuca; H K Schnoes
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

3.  A rapid method for measurement of fractional intestinal absorption of calcium.

Authors:  J Chanard; J Assailly; C Bader; J L Funck-Brentano
Journal:  J Nucl Med       Date:  1974-07       Impact factor: 10.057

4.  Immunoradiometric assay of parathyroid hormone.

Authors:  G M Addison; C N Hales; J S Woodhead; J L O'Riordan
Journal:  J Endocrinol       Date:  1971-03       Impact factor: 4.286

5.  Nomogram for derivation of renal threshold phosphate concentration.

Authors:  R J Walton; O L Bijvoet
Journal:  Lancet       Date:  1975-08-16       Impact factor: 79.321

6.  Parathyroid function in sarcoidosis.

Authors:  W G Cushard; A B Simon; J M Canterbury; E Reiss
Journal:  N Engl J Med       Date:  1972-02-24       Impact factor: 91.245

7.  Hyperparathyroidism and sarcoidosis.

Authors:  C E Dent; L Watson
Journal:  Br Med J       Date:  1966-03-12

8.  Measurement of 1,25-dihydroxycholecalciferol in man by radioimmunoassay.

Authors:  T L Clemens; G N Hendy; S E Papapoulos; L J Fraher; A D Care; J L O'Riordan
Journal:  Clin Endocrinol (Oxf)       Date:  1979       Impact factor: 3.478

9.  Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors:  N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

10.  1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.

Authors:  S E Papapoulos; T L Clemens; L J Fraher; I G Lewin; L M Sandler; J L O'Riordan
Journal:  Lancet       Date:  1979-03-24       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.